Pharmaceutica-2012

    Previous Events
     
     
    Participants List in Academia
    Untitled Document
    King Saud University, Soudi Arabia

    University of Minnesota, USA

    Veer Narmad South Gujarat University, India

    Karolinska Institute, Sweden

    Bharati Vidyapeeth Deemed University, India

    University of Valencia, Spain

    Griffith University, Australia

    Mahidol University, Thailand

    SRTM University, India

    Zhengzhou University, China

    University College London, UK

    Shanghai University of Traditional Chinese Medicine, China

    University of Calcutta, India

    Universiti Sains, Malaysia

    Michigan State University, USA

    University of Porto, Portugal

    University of Madras, India

    Jamia Hamdard, India

    Sogang University, India

    Indian Institute Of Technology, India

    Anadolu University, Turkey

    Moscow State University, Russia

    Gunma University, Japan

    Chung-Ang University, Korea

    Nirma University, India

    Tehran University of Medical Sciences, Iran

    University of Rome, Italy

    Guru Nanak Institute of Engineering, India

     
    Participants List in Business
    Untitled Document
    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Women’s Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddy’s labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST) , India

    Novartis Campus, Austria


     
    Upcoming Conferences
    Day 1   Day 2   Day 3

    OMICS Group's 2nd International Conference on Pharmaceutics & Novel Drug Delivery Systems


    Theme: To showcase the cutting edge technologies in Pharmaceutics & Strategies of Drug Delivery.

    Dates : February 20-22, 2012
    Venue: San Francisco Airport Marriott, USA

    Tel: Fax: Toll Free:
    +1-650-268-9744 +1-650-618-1417 +1-800-216-6499

    Website:
    https://www.omicsonline.org/pharmaceutica2012/
    Submit Your Abstract Online at: https://www.omicsonline.org/pharmaceutica2012/abstract.php
    (or)
    E-mail to: pharmaceutica2012@omicsonline.org

    We warmly invite you to attend and submit your abstract to 2nd International Conference on Pharmaceutics & Novel Drug Delivery Systems
     
    Pharmaceutica-2012 is comprised of 10 tracks and 43 sessions designed to offer comprehensive sessions that address current issues in Pharmaceutics & Drug Delivery Research. You can register the whole conference or select a single track or register for special service package that you want for your participation. Abstracts for the following proposed or related topics are accepted.
     
    Please submit your abstract to any of the following tracks.
    Track 1: New Technology of Drug Delivery Systems
    Track 1-1: Sustained, Controlled or Modified-release Drug Delivery
    Track 1-2: Prodrugs for Better Efficacy
    Track 1-3: Electronically Controlled Drug Delivery Sysytems
    Track 1-4: Biocompatible Polymers and Biopolymers
    Track 1-5: Formulation and Drug Delivery Development of Poorly Soluble Drugs
    Track 1-6: Gene and Cell Therapy
    Track 2: Development of Personalized Medicine
    Track 3: Biopharmaceuticals Development
    Track 3-1: Biopharmaceutics and Formulation Development
    Track 3-2: Role of PK/PD in Product Development
    Track 3-3: Drug Development of Pediatrics: Formulation and Regulatory Aspects
    Track 3-4: Bioavailability and Bioequivalence in Disease State
    Track 4: Identification and Characterization of Drugs
    Track 4-1: Characterization of Synthetic and Natural Products
    Track 4-2: Structural Analysis: Characterization of Process or Product Related Impurities and Degradants
    Track 4-3: Instrumental Methods for Identification and Characterization
    Track 4-4: Metabolite Characterization: Drug Discovery
    Track 4-5: Advanced Techniques in Structure Characterization
    Track 5: Quality Management System in Pharmaceutical Industry
    Track 5-1: Pharmaceutical Development & Quality Systems
    Track 5-2: Quality Assurance and Quality Control for Pharmaceutical Development
    Track 5-3: Quality Assessment for Pharmaceutical Products
    Track 5-4: Food and Drug Safety
    Track 5-5: Quality by Design: Broadening the Application and Sharing the Learnings
    Track 6: Pharmacokinetic Considerations of Drug Delivery
    Track 6-1: Pharmacokinetic Parameters for Drug Disposotion
    Track 6-2: Pharmacokinetic Parameters for Drug Input
    Track 6-3: Pharmacokinetic Model for Presystemic Metabolism
    Track 6-4: BA/BE studies of Pharmacokinetic Drug Interactions
    Track 7: Trends in Drug Delivery Systems of Global Market
    Track 7-1: Global Needs and Strategies for Novel Dosage Forms
    Track 7-2: Generic Development of Drug Delivery Systems
    Track 7-3: Product Planning, Technology Evaluation and Product/Brand Management
    Track 7-4: Successful Drug Discovery from the Research Lab to the Marketplace
    Track 8: Novel Drug Delivery System Technology Targeting Different Route of Administration
    Track 8-1: Oral, Transmuco Adhesive and Buccal Drug Delivery
    Track 8-2: Rectal and Vaginal Drug Delivery
    Track 8-3: Nasal and Inhalable Drug Delivery
    Track 8-4: Transdermal and Topical Drug Delivery
    Track 8-5: Ocular Drug Delivery
    Track 8-6: Novel Approaches in Drug Delivery
    Track 9: Nanotech for Drug Delivery
    Track 9-1: Biocompatible and Biodegradable Materials for Drug Nanoparticles
    Track 9-2: Controlled Delivery of Nanoparticles in DDS
    Track 9-3: Nanoparticles as Drug Carrier in DDS
    Track 9-4: Site-Directed Controlled Nano-drug Delivery Systems
    Track 10: Regulatory Issues, Quality Control, and Business Development
    Track 10-1: Clinical Trials in Emerging Markets
    Track 10-2: Benefit/Risk Assessment during Drug Development
    Track 10-3: Safety and Quality Regulation
    Track 10-4: Pharmacovigilance and Safety management
    Track 10-5: Regulatory challenges in Nano and Biotech Therapeutics
     
    follow
    Conference Secretariat: Pharmaceutica-2012, OMICS Publishing Group
    5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA.
    Tel: +1-650-268-9744 l Fax: +1-650-618-1417
    Toll free: 1-800-216-6499(USA & Canada), 1-800-651-097(Australia), 0805-080048(Europe)
    Email: pharmaceutica2012@omicsonline.org l www.omicsonline.org
    Operated by: Editors - Pharmaceutics & Drug Delivery Research, Pharmaceutica Analytica Acta
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2011 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version